Hematopoietic cell transplants in Jordan: different indications from the US and EU
Bone Marrow Transplant
.
2019 Sep;54(9):1379-1381.
doi: 10.1038/s41409-019-0578-1.
Epub 2019 May 31.
Authors
Khalid Halahleh
1
,
Mahmoud M Sarhan
2
,
Robert Peter Gale
3
,
Hasan Hashem
4
,
Eman Khattab
4
,
Waleed Da'na
4
,
Mohammad Ma'koseh
4
,
Mayada Abu Shanab
4
,
Maha Yousef
4
,
Laiali Khalil
5
,
Nilly Hussein
4
,
Shanta Sharma
6
,
Husam Abujazar
4
,
Rawad Rihani
4
,
Abdelghani Tbakhi
6
,
Abdulla Al Abadi
5
6
Affiliations
1
King Hussein Cancer Center, Amman, Jordan. kh.06314@khcc.jo.
2
Arab Medical Centre, Amman, Jordan.
3
Imperial College London, London, UK.
4
King Hussein Cancer Center, Amman, Jordan.
5
Jordan University Hospital, Amman, Jordan.
6
Departments of Cell Therapy & Applied Genomics, Amman, Jordan.
PMID:
31150017
DOI:
10.1038/s41409-019-0578-1
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't
MeSH terms
European Union
Hematopoietic Stem Cell Transplantation*
Humans
Jordan
Transplantation, Autologous
Transplantation, Homologous
United States
Grants and funding
DH_/Department of Health/United Kingdom